Outlook on the Disposable Lead Wires Global Market to 2030 – Featuring Schiller, OSI Systems and Conmed Among Others

The “Disposable Lead Wires Market Size, Share & Trends Analysis Report by Material (TPE, TPU, Silicone, PVC), by Machine Type (3 Lead, 5 Lead, 12 Lead, 6 Lead), by End-use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global disposable lead wires market size is expected to reach USD 1.7 billion by 2030, registering a CAGR of 6.6%. Rising incidence of hospital-acquired infections (HAIs) is the key driving factor for the market growth.

The reusable lead wires are the major cause of hospital-acquired bloodstream infections. The use of disposable lead wires eliminates the risk of cross-contamination. In addition, it reduces the cost associated with HAIs. The aforementioned benefits are presumed to boost the usage rates over the forecast period.

As per the data published by the University of Wisconsin Hospital and Clinics, Madison, more than 77% of cases of contamination with Multidrug-Resistant Bacterial Pathogens (MRSA, Vancomycin-Resistant Enterococci (VRE) were connected with the use of reusable ECG lead wires in hospitalized patients.

According to World Health Organization (WHO), 7 out of every 100 hospitalized patients will develop hospital-acquired infections in developed countries, whereas, the number will increase to 10 in developing countries due to poor healthcare infrastructure. The rate of ICU-acquired infections is at least 2-3 times higher in developing countries. Hence, significant demand for these products prevails due to such factors.

Moreover, the rising number of government initiatives to promote the incorporation of patient safety procedures in hospital settings is presumed to drive the overall market growth during the forecast period. Furthermore, an introduction of technologically advanced disposable LWs is anticipated to drive the market growth during the forecast period. For instance, advanced disposable ECG-LWs with patented push-button design have superior capabilities in reducing alarms that are created by a failure of leads and the absence of telemetry. These above-mentioned factors are anticipated to fuel the market growth.

Disposable Lead Wires Market Report Highlights

  • Thermoplastic Elastomer (TPE) is expected to witness lucrative growth during the forecast period, owing to the rising adoption to reduce infection rates in healthcare facilities.
  • The advantages of TPE over other materials like PVC and rubber latex such as providing better flexibility, ease of processing enabling high performance in a variety of applications.
  • The demand for the 5-lead machine type is expected to increase in coming years owing to the surge in demand for cost-effective equipment in critical care settings.
  • Ambulatory care centers are presumed to witness exponential growth throughout the forecast period. This can be attributed to the rising significance of disposable LWs inpatient monitoring.
  • North America accounted for the largest share in the market for disposable lead wires, owing to the rising mortality rates pertaining to heart diseases.
  • The Asia Pacific is anticipated to witness lucrative growth as a result of unmet patient needs, rising healthcare expenditure, and the establishment of major global players is expected to drive segment growth during the forecast period.
  • The key players are involved in strategic alliances to sustain the competition, such as mergers & acquisitions, strategic partnerships, and geographic expansion.

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Disposable Lead Wires Market Variables, Trends & Scope
3.1 Market Segmentation& Scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing incidence of hospital acquired infections
3.1.1.2 Increasing prevalence of cardiovascular diseases
3.1.1.3 Technological advancement
3.1.1.4 Increasing demand for disposable devices
3.1.2 Market Restraint Analysis
3.1.2.1 Lack of reimbursement policies
3.2 Penetration & Growth Prospect Mapping
3.3 Disposable Lead Wires- PESTLE Analysis
3.4 Industry Analysis-Porter’s

Chapter 4 Disposable Lead Wires: Materials Estimates & Trend Analysis
4.1 Disposable Lead Wires Market: Materials Movement Analysis
4.2 Thermoplastic elastomer (TPE)
4.2.1 TPE market, 2018-2030 (USD Million)
4.3 Thermoplastic polyurethane (TPU)
4.3.1 TPU market, 2018-2030 (USD Million)
4.4 Others
4.4.1 Others market, 2018-2030 (USD Million)

Chapter 5 Disposable Lead Wires: Machine Type Estimates & Trend Analysis
5.1 Disposable Lead Wires Market: Machine Type Movement Analysis
5.2 3 Lead
5.2.1 3 lead market, 2018-2030 (USD Million)
5.3 5Lead
5.3.1 5 lead market, 2018-2030 (USD Million)
5.4 Others
5.4.1 Others market, 2018-2030 (USD Million)

Chapter 6 Disposable Lead Wires: End-use Estimates & Trend Analysis
6.1 Disposable Lead Wires Market: End-use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals market, 2018-2030 (USD Million)
6.3 Clinics
6.3.1 Clinics market, 2018-2030 (USD Million)
6.4 Long term Facilities
6.4.1 Long term facilities market, 2018-2030 (USD Million)
6.5 Ambulatory and Home Care
6.5.1 Ambulatory and home care market, 2018-2030 (USD Million)

Chapter 7 Disposable Lead Wires: Regional Estimates & Trend Analysis, by Materials, Machine Type, and End-use

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 3M Company
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.2 BD and Company
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.3 Mindray Medical International Limited
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.4 Carlisle Medical Technologies
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.5 Schiller AG
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.6 OSI Systems, Inc.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.7 Conmed Corporation
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.8 Welch Allyn, Inc
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Curbell Medical Products, Inc
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.10 Cardinal Health
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version